MINUTOLO, Roberto
 Distribuzione geografica
Continente #
EU - Europa 14.892
NA - Nord America 8.582
AS - Asia 6.907
SA - Sud America 1.041
AF - Africa 90
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 31.526
Nazione #
RU - Federazione Russa 9.757
US - Stati Uniti d'America 8.461
SG - Singapore 2.283
IE - Irlanda 1.598
CN - Cina 1.486
HK - Hong Kong 1.057
BR - Brasile 883
UA - Ucraina 828
VN - Vietnam 687
GB - Regno Unito 684
IT - Italia 658
IN - India 516
DE - Germania 460
KR - Corea 269
FI - Finlandia 238
TR - Turchia 229
SE - Svezia 220
GR - Grecia 127
BD - Bangladesh 86
FR - Francia 80
JP - Giappone 79
CA - Canada 64
AR - Argentina 55
AT - Austria 54
BE - Belgio 38
NL - Olanda 34
IQ - Iraq 30
EC - Ecuador 28
MX - Messico 28
CZ - Repubblica Ceca 26
ES - Italia 26
PK - Pakistan 25
ZA - Sudafrica 24
ID - Indonesia 20
PH - Filippine 18
VE - Venezuela 18
CO - Colombia 15
MA - Marocco 15
PY - Paraguay 15
MY - Malesia 14
CL - Cile 12
IR - Iran 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
LT - Lituania 9
PL - Polonia 9
KE - Kenya 8
KZ - Kazakistan 8
TH - Thailandia 8
TN - Tunisia 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
EG - Egitto 7
IL - Israele 7
JM - Giamaica 7
EU - Europa 6
NI - Nicaragua 6
RS - Serbia 6
SC - Seychelles 6
AU - Australia 5
NP - Nepal 5
TW - Taiwan 5
AL - Albania 4
CR - Costa Rica 4
GE - Georgia 4
JO - Giordania 4
OM - Oman 4
PE - Perù 4
BG - Bulgaria 3
BO - Bolivia 3
ET - Etiopia 3
GA - Gabon 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
KH - Cambogia 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
RW - Ruanda 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 31.502
Città #
Moscow 3.478
Dublin 1.595
Jacksonville 1.247
Hong Kong 1.052
Santa Clara 982
Singapore 951
Chandler 896
San Jose 887
Chicago 484
Bengaluru 461
Ashburn 341
Seoul 255
Hefei 254
Princeton 242
Ho Chi Minh City 241
Wilmington 224
Medford 207
Hanoi 170
Beijing 163
Boardman 154
Roxbury 150
Ann Arbor 139
Dallas 138
Falls Church 133
San Mateo 121
Naples 99
Woodbridge 97
The Dalles 96
São Paulo 93
New York 90
Los Angeles 71
Munich 63
Nanjing 58
Des Moines 57
Istanbul 56
Caserta 54
Bremen 53
Cambridge 39
Jinan 39
Brussels 38
Da Nang 38
Milan 35
Haiphong 32
Saint Petersburg 32
Houston 31
Mountain View 28
Belo Horizonte 27
Norwalk 26
Nuremberg 26
Zhengzhou 26
Napoli 25
Tianjin 25
Vienna 25
Rio de Janeiro 24
Shenyang 24
Guangzhou 23
Rome 23
Brno 22
Helsinki 20
Orem 20
Ercolano 19
Turku 19
Atlanta 18
Frankfurt am Main 18
Toronto 18
Shanghai 17
Bologna 16
Changsha 16
Curitiba 16
Hangzhou 16
Chennai 15
London 15
Tokyo 15
Brooklyn 14
Falkenstein 14
Johannesburg 13
Nanchang 13
Ningbo 13
Auburn Hills 12
Council Bluffs 12
Hải Dương 12
Seattle 12
Nha Trang 11
Taizhou 11
Amsterdam 10
Dhaka 10
Florence 10
Mexico City 10
Phoenix 10
Porto Alegre 10
Quito 10
San Francisco 10
Zanjan 10
Asunción 9
Baghdad 9
Biên Hòa 9
Boston 9
Columbus 9
Jiaxing 9
Lahore 9
Totale 17.008
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 834
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 235
Empagliflozin in Patients with Chronic Kidney Disease 228
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 191
Amino acid loss during dialysis treatment 179
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 176
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 176
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 174
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 173
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 170
[Anti-diabetics and chronic kidney disease] 170
[Hyperuricaemia and Chronic Kidney Disease] 168
[Iron deficiency in ND-CKD: from diagnosis to treatment] 167
AISF position paper on HCV in immunocompromised patients 166
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 164
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 164
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 163
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 161
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 161
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 160
Daily nutrient intake in hemodialysis. 158
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 158
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 156
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 156
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 153
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 153
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 152
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 152
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 152
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 151
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 151
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 151
[Epidemiology and prognosis of chronic kidney disease in Italy] 151
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 151
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 149
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 147
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 142
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 141
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 141
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 140
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 139
Disfunzione renale nell’anziano: processo fisiologico o malattia? 139
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 138
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 137
Epidemiology of chronic kidney disease in Italy: the CARHES study 137
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 137
Epidemiology of CKD Regression in Patients under Nephrology Care 137
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 135
Management of hypertension in chronic kidney disease: the Italian multicenter study. 134
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 134
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 134
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 134
Anemia: A Connection Between Heart Failure and Kidney Failure 133
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 132
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 132
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 132
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 131
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 131
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 131
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 130
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 129
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 129
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 129
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 129
Management of hypertension in chronic kidney disease 128
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 128
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 127
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 127
Epidemiology of chronic kidney disease in Italy 127
ESA, iron therapy and new drugs: Are there new perspectives in the treatment of anaemia? 127
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 126
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 126
Heart Failure in chronic kidney disease: from epidemiology to therapy. 126
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. 126
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 126
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 126
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 125
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 125
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 125
[Antihypertensive treatment in the nephropathic patient] 125
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 124
Are all erythropoiesis-stimulating agents created equal? 124
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 123
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 123
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 123
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 122
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe 121
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 121
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis 120
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 120
Effects of age on hypertensive status in patients with chronic kidney disease 119
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 119
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 119
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials 118
Epoetin therapy and hemoglobin level variability in non-dialysis CKD patients 118
Clinical policies on the management of chronic kidney disease patients in Italy 118
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 118
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 118
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 118
Totale 14.819
Categoria #
all - tutte 107.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 0 49
2021/20221.760 154 42 42 72 523 15 36 51 64 144 158 459
2022/20233.530 315 108 313 287 327 289 9 211 1.496 36 62 77
2023/20241.205 116 44 53 113 447 63 29 20 17 23 84 196
2024/20254.103 12 72 59 121 648 577 586 346 446 671 315 250
2025/202616.832 699 1.029 854 751 1.291 9.172 874 795 610 393 230 134
Totale 31.903